查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356792

排卵症診斷市場報告：2030 年趨勢、預測與競爭分析

Ovulation Disorder Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

排卵障礙診斷的趨勢和預測

到 2030 年，全球排卵症診斷市場預計將達到 8 億美元，2024 年至 2030 年年複合成長率為 6.1%。這個市場的主要促進因素是擴大採用計劃懷孕、人們對各種排卵障礙的認知不斷提高以及出生率下降。全球排卵障礙診斷市場的未來前景廣闊，醫院、婦科診所和診斷中心市場充滿機會。

排卵障礙診斷市場洞察

Lucintel 預測，由於第 2 型糖尿病患者 PCOD 發病率不斷增加，多囊性卵巢症候群預計在預測期內成長最快。

醫院仍然是該市場中最大的部分。

由於先進的醫療基礎設施和公眾對排卵障礙診斷意識的提高，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球排卵症診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球排卵症診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 按排卵障礙分類的全球排卵障礙診斷市場
    • 多囊性卵巢症候群
    • 高催乳素血症
    • 黃體期不足
    • 下視丘功能障礙
    • 瘤
    • 自體免疫卵巢炎
    • 原發性卵巢功能衰竭
    • 抵抗性卵巢症候群
    • 其他
  • 全球排卵症診斷市場（按診斷）
    • 荷爾蒙實驗室測試
    • 腦下垂體和下視丘的 CT 和 MRI 掃描
    • 卵巢切片檢查
    • 其他
  • 全球排卵障礙診斷市場（按最終用途）
    • 醫院
    • 婦科門診
    • 診斷中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球排卵障礙診斷市場
  • 北美排卵障礙診斷市場
  • 歐洲排卵症診斷市場
  • 亞太排卵症診斷市場
  • 其他區域排卵障礙診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 排卵障礙在全球排卵障礙診斷市場的成長機會
    • 全球排卵症診斷市場診斷成長機會
    • 全球排卵障礙診斷市場的成長機會（以最終用途）
    • 按地區分類的全球排卵障礙診斷市場成長機會
  • 全球排卵症診斷市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球排卵障礙診斷市場的產能
    • 全球排卵障礙診斷市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • LabCorp
  • Esaote
簡介目錄

Ovulation Disorder Diagnosis Trends and Forecast

The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets. The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

A more than 150-page report is developed to help in your business decisions.

Ovulation Disorder Diagnosis by Segment

The study includes a forecast for the global ovulation disorder diagnosis by ovulation disorders, diagnosis, end use, and region.

Ovulation Disorder Diagnosis Market by Ovulation Disorders [Shipment Analysis by Value from 2018 to 2030]:

  • Polycystic Ovarian Syndrome
  • Hyperprolactinemia
  • Luteal Phase Defect
  • Hypothalamus Dysfunction
  • Tumors
  • Autoimmune Oophoritis
  • Primary Ovarian Failure
  • Resistant Ovary Syndrome
  • Others

Ovulation Disorder Diagnosis Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Laboratory Testing of Hormones
  • CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
  • Ovarian Biopsy
  • Others

Ovulation Disorder Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Gynecological Clinics
  • Diagnostic Centers
  • Others

Ovulation Disorder Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ovulation Disorder Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ovulation disorder diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ovulation disorder diagnosis companies profiled in this report include-

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • Labcorp
  • Esaote

Ovulation Disorder Diagnosis Market Insights

Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Within this market, hospitals will remain the largest segment .

North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Features of the Global Ovulation Disorder Diagnosis Market

Market Size Estimates: Ovulation disorder diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ovulation disorder diagnosis market size by ovulation disorders, diagnosis, end use, and region. in terms of value ($B).

Regional Analysis: Ovulation disorder diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different ovulation disorders, diagnosis, end uses, and region.s for the ovulation disorder diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ovulation disorder diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the ovulation disorder diagnosis market size?

Answer: The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for ovulation disorder diagnosis market?

Answer: The global ovulation disorder diagnosis market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the ovulation disorder diagnosis market?

Answer: The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

Q.4. What are the major segments for ovulation disorder diagnosis market?

Answer: The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets.

Q.5. Who are the key ovulation disorder diagnosis market companies?

Answer: Some of the key ovulation disorder diagnosis companies are as follows:

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • LabCorp
  • Esaote

Q.6. Which ovulation disorder diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Q.7. In ovulation disorder diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ovulation disorder diagnosis market by ovulation disorders (polycystic ovarian syndrome, hyperprolactinemia, luteal phase defect, hypothalamus dysfunction, tumors, autoimmune oophoritis, primary ovarian failure, resistant ovary syndrome, and others), diagnosis (laboratory testing of hormones, CT scan & MRI scan of the pituitary gland & hypothalamus, ovarian biopsy, and others), end use (hospitals, gynecological clinics, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ovulation Disorder Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ovulation Disorder Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
    • 3.3.1: Polycystic Ovarian Syndrome
    • 3.3.2: Hyperprolactinemia
    • 3.3.3: Luteal Phase Defect
    • 3.3.4: Hypothalamus Dysfunction
    • 3.3.5: Tumors
    • 3.3.6: Autoimmune Oophoritis
    • 3.3.7: Primary Ovarian Failure
    • 3.3.8: Resistant Ovary Syndrome
    • 3.3.9: Others
  • 3.4: Global Ovulation Disorder Diagnosis Market by Diagnosis
    • 3.4.1: Laboratory Testing of Hormones
    • 3.4.2: CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
    • 3.4.3: Ovarian Biopsy
    • 3.4.4: Others
  • 3.5: Global Ovulation Disorder Diagnosis Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Gynecological Clinics
    • 3.5.3: Diagnostic Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ovulation Disorder Diagnosis Market by Region
  • 4.2: North American Ovulation Disorder Diagnosis Market
    • 4.2.2: North American Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.3: European Ovulation Disorder Diagnosis Market
    • 4.3.1: European Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.3.2: European Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Ovulation Disorder Diagnosis Market
    • 4.4.1: APAC Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.4.2: APAC Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Ovulation Disorder Diagnosis Market
    • 4.5.1: ROW Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.5.2: ROW Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
    • 6.1.2: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Ovulation Disorder Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ovulation Disorder Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovulation Disorder Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthcare
  • 7.2: GE Healthcare
  • 7.3: Fujifilm Holdings
  • 7.4: Swiss Precision Diagnostics
  • 7.5: Toshiba Medical Systems
  • 7.6: Carestream Health
  • 7.7: Genova Diagnostics
  • 7.8: Quest Diagnostics
  • 7.9: LabCorp
  • 7.10: Esaote